Abhijeet Satwekar
Abhijeet Satwekar publishes mostly in Molecular Biology, Pulmonary and Respiratory Medicine and Immunology, on topics such as Blood properties and coagulation, Protein purification and stability and Viral Infectious Diseases and Gene Expression in Insects.
- World rank
- #2,432,496 of 7,710,434 ranked researchers
- Rank in Italy
- #81,528 of 242,206
- Works
- 25
- Citations
- 284
- Citations per work
- 11.4
What does Abhijeet Satwekar research?
Abhijeet Satwekar's work is mostly in Biochemistry, Genetics and Molecular Biology (34%), Medicine (26%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1040.0%
- Everything else834.0%
- Health Sciences626.0%
- Medicine626.0%
- 1Molecular Biology28% of their works
- 2Pulmonary and Respiratory Medicine14% of their works
- 3Immunology6% of their works
- 4Radiology, Nuclear Medicine and Imaging6% of their works
- 5Public Health, Environmental and Occupational Health6% of their works
- 6Biotechnology6% of their works
Research topics
- Blood properties and coagulation
- Protein purification and stability
- Viral Infectious Diseases and Gene Expression in Insects
- Glycosylation and Glycoproteins Research
- Monoclonal and Polyclonal Antibodies Research
- Enzyme Production and Characterization
- Biosimilars and Bioanalytical Methods
- Computational Drug Discovery Methods
Which keywords describe Abhijeet Satwekar's research?
The keywords of their largest research topics: Monoclonal Antibodies, Glycosylation, Therapeutic Antibodies, Biopharmaceuticals, Immunogenicity, Fibrinogen, Transglutaminases and Protein Aggregation.
- Molecular Docking
- Biotechnological Applications
- Bioanalytical Methods
- Fc Receptors
- Antibody Engineering
- Mammalian Cells
- Protein Aggregation
- Fibrinogen
- Biopharmaceuticals
- Glycosylation
- Monoclonal Antibodies
- Therapeutic Antibodies
- Immunogenicity
- Transglutaminases
- Recombinant Proteins
- Recombinant Protein
- Cancer
- Glycans
- Biosimilars
- Microbial Enzymes
- Virtual Screening
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Monoclonal Antibodies113 topics
- Glycosylation103 topics
- Therapeutic Antibodies92 topics
- Biopharmaceuticals82 topics
- Immunogenicity82 topics
- Fibrinogen71 topic
- Transglutaminases71 topic
- Protein Aggregation61 topic
- Recombinant Proteins61 topic
- Mammalian Cells41 topic
- Recombinant Protein41 topic
- Antibody Engineering31 topic
- Cancer31 topic
- Fc Receptors31 topic
- Glycans31 topic
- Bioanalytical Methods21 topic
- Biosimilars21 topic
- Biotechnological Applications21 topic
- Microbial Enzymes21 topic
- Molecular Docking21 topic
- Virtual Screening21 topic
Where does Abhijeet Satwekar work?
Abhijeet Satwekar's main affiliation in the publication record is Merck Serono S.p.A. (Italy), Italy.
How many publications and citations does Abhijeet Satwekar have?
OpenAlex counts 25 works and 284 citations for Abhijeet Satwekar, an h-index of 8, ranking #2,432,496 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Abhijeet Satwekar. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.